MedPath

Efficacy of Poststroke Intensive Rosuvastatin Treatment for Aortogenic Embolic Stroke (EPISTEME trial)

Not Applicable
Conditions
Brain infarction or transient ischemic attack with atheromatous plaques in the aortic arch
Registration Number
JPRN-UMIN000010548
Lead Sponsor
Department of Neurology, Juntendo Universiy School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients during pregnancy or lactation 2) Allergy against statin 3) Patients with coronary artery disease and requiring statin therapy 4) Patients with severe renal dysfunction or liver dysfunction 5) Patients undergoing cyclosporin therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Morphological alteration of atheromatous plaques in the aortic arch
Secondary Outcome Measures
NameTimeMethod
1) Alteration of atheromatous plaques in the aortic arch 2) Changes in lipid profile 3) Changes in inflammatory markers and white blood cell count 4) Recurrence of ischemic stroke 5) Prevalence of hemorrhagic stroke including intracranial brain hemorrhage and subarachnoid hemorrhage 6) Prevalence of coronary artery disease 7) Other vascular diseases 8) Death
© Copyright 2025. All Rights Reserved by MedPath